| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,4 M € | -1.5% | 3,4 M € | -32.6% | 5,1 M € | +30.8% | 3,9 M € | +22.6% | 3,2 M € | +73.8% | 1,8 M € | -24.8% | 2,4 M € | -4.9% | 2,6 M € | +10.5% | 2,3 M € | -9.5% | 2,6 M € | — | — | — | — | — | — | — | ||||||||
| Gross margin | — | — | — | — | — | — | — | — | — | — | 466,2 k € | -45.4% | 854,2 k € | +182.0% | 302,9 k € | +214.2% | 96,4 k € | -32.3% | 142,4 k € | +632.8% | -26,7 k € | -19.2% | -22,4 k € | |||||||||||
| EBITDA | 95,2 k € | +490.8% | -24,4 k € | -105.3% | 455,6 k € | +397.4% | -153,2 k € | -127.8% | 551,2 k € | +213.0% | -487,9 k € | -468.0% | 132,6 k € | -28.1% | 184,4 k € | +186.0% | -214,5 k € | -2069.9% | 10,9 k € | +103.5% | -313,9 k € | -136.7% | 854,2 k € | +182.0% | 302,9 k € | +214.2% | 96,4 k € | -32.3% | 142,4 k € | +632.8% | -26,7 k € | -19.2% | -22,4 k € | |
| Operating profit | 95,2 k € | +490.8% | -24,4 k € | -105.3% | 455,6 k € | +397.4% | -153,2 k € | -127.8% | 551,2 k € | +213.0% | -487,9 k € | -468.0% | 132,6 k € | -23.2% | 172,6 k € | +180.6% | -214,1 k € | -4405.1% | 5,0 k € | +101.5% | -322,9 k € | -137.8% | 854,2 k € | +213.0% | 272,9 k € | +183.1% | 96,4 k € | -32.3% | 142,4 k € | +632.8% | -26,7 k € | -19.2% | -22,4 k € | |
| Profit/loss | 95,0 k € | +480.9% | -24,9 k € | -105.5% | 454,5 k € | +390.4% | -156,5 k € | -128.4% | 550,7 k € | +212.8% | -488,1 k € | -468.5% | 132,5 k € | +15.8% | 114,4 k € | +153.4% | -214,2 k € | -4407.2% | 5,0 k € | +100.5% | -1,0 M € | -222.0% | 852,0 k € | +210.1% | 274,8 k € | +165.6% | 103,5 k € | -27.4% | 142,5 k € | +761.7% | -21,5 k € | -37.7% | -15,6 k € | |
| Equity | 865,5 k € | +12.3% | 770,5 k € | -3.1% | 795,4 k € | +135.5% | 337,8 k € | -31.7% | 494,3 k € | +976.8% | -56,4 k € | -113.1% | 431,7 k € | +44.3% | 299,3 k € | +61.9% | 184,9 k € | -55.8% | 418,3 k € | +1.2% | 413,3 k € | -71.6% | 1,5 M € | +141.8% | 600,9 k € | +84.3% | 326,1 k € | +46.5% | 222,6 k € | -53.3% | 477,2 k € | -4.3% | 498,7 k € | |
| Total assets | 1,7 M € | +15.7% | 1,5 M € | -15.8% | 1,8 M € | +54.7% | 1,1 M € | -1.6% | 1,2 M € | +98.5% | 583,6 k € | -41.3% | 994,6 k € | +40.6% | 707,6 k € | -3.2% | 731,4 k € | -23.9% | 961,3 k € | +11.5% | 862,2 k € | -47.5% | 1,6 M € | +153.9% | 647,2 k € | +9.6% | 590,5 k € | +3.4% | 571,2 k € | -34.0% | 865,9 k € | -14.6% | 1,0 M € | |
| Cash | 1,0 M € | +0.7% | 1,0 M € | -4.4% | 1,1 M € | +49.0% | 714,9 k € | +3.3% | 692,1 k € | +164.3% | 261,8 k € | -56.5% | 601,6 k € | +226.7% | 184,2 k € | -44.8% | 333,8 k € | +1.9% | 327,6 k € | +2.4% | 320,0 k € | -30.8% | 462,2 k € | +123.3% | 207,0 k € | +58.2% | 130,9 k € | +6.4% | 123,0 k € | +19.7% | 102,7 k € | -72.2% | 369,3 k € | |
| Debts | 483,9 k € | -3.8% | 502,8 k € | -35.0% | 773,2 k € | +47.6% | 523,8 k € | +30.6% | 401,2 k € | +5.9% | 378,8 k € | +74.3% | 217,3 k € | -12.3% | 247,7 k € | -38.8% | 404,8 k € | +16.2% | 348,3 k € | +25.4% | 277,6 k € | +2089.9% | 12,7 k € | -55.2% | 28,3 k € | -85.0% | 188,5 k € | -27.1% | 258,7 k € | +37.3% | 188,4 k € | -40.0% | 313,9 k € | |
| Staff | 8 | 10,5 | 13 | 10 | 8 | 7 | 5,3 | 8 | 8 | 6,8 | 6 | — | — | — | — | — | — | |||||||||||||||||
International non-profit organization · Woluwe-Saint-Lambert · incorporated on 07/11/1994 · 8,0 ETP
International non-profit organization profitable and well capitalised.
Solid counterparty for a standard engagement.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE is a International non-profit organization incorporated in 1994. Its main activity is: Management consultancy activities. Its registered office is in Woluwe-Saint-Lambert. It employs on average 8,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette